“Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement”

Authors: Guido Lancman, Kevin Song, Darrell White, Tina Crosbie, Ismail Sharif, Marianne Emond, Muhammad Saleem Raza, Martine Elias, Rayan Kaedbey and Michael P. Chu

“Here, we have presented a set of recommendations for optimizing the use of T-cell–redirecting therapy in a Canadian context. This set of recommendations, which is expected to evolve in the future, includes strategies to improve and optimize referral pathways, coordination of care, patient selection, clinical decision-making, and adverse event management. Implementation of these protocols is expected to streamline health care resource utilization, expand access to T-cell–redirecting therapies, and improve patient outcomes, including safety, for patients with RRMM in Canada.”

Read the article.